We may speculate that downregulated GSK-3β activity by vitamin D supplementation could lead to less NF-κB activation, decreasing cytokine production and thus, forming a feed-forward mechanism and further reducing the development of insulin resistance. This evidence concerns the gene NFKB1 and Insulin resistance.